Stephanie Guillet

University Paris Est Créteil
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study.

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study.

Journal: British journal of haematology

Published: April 02, 2026

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).

Journal: BMJ open

Published: September 18, 2025

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia.

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia.

Journal: British journal of haematology

Published: July 04, 2025

Repeat biopsies in membranous lupus nephritis in the era of target antigen identification.

Repeat biopsies in membranous lupus nephritis in the era of target antigen identification.

Journal: Virchows Archiv : an international journal of pathology

Published: April 10, 2025

ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

Journal: eLife

Published: November 21, 2024

Long-term follow-up of the STOPAGO study.

Long-term follow-up of the STOPAGO study.

Journal: Blood

Published: June 24, 2024

ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

Journal: medRxiv : the preprint server for health sciences

Published: June 17, 2024

Immune thrombocytopenia newly diagnosed during pregnancy: Outcome for mothers and neonates and comparison with chronic immune thrombocytopenia during pregnancy.

Immune thrombocytopenia newly diagnosed during pregnancy: Outcome for mothers and neonates and comparison with chronic immune thrombocytopenia during pregnancy.

Journal: American journal of hematology

Published: May 07, 2024

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

Journal: Blood

Published: October 27, 2022

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.

Journal: European journal of haematology

Published: July 03, 2022

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Journal: Blood

Published: June 09, 2022

Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.

Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.

Journal: British journal of haematology

Published: July 16, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026